|
1
|
Zhao Z, Yin Z and Zhao Q: Red and
processed meat consumption and gastric cancer risk: A systematic
review and meta-analysis. Oncotarget. 8:30563–30575. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuan X, Meng Y, Li P, Ge N, Kong F, Yang
L, Björkholm M, Zhao S and Xu D: The association between the TERT
rs2736100 AC genotype and reduced risk of upper tract urothelial
carcinomas in a Han Chinese population. Oncotarget. 7:31972–31979.
2016.PubMed/NCBI
|
|
3
|
Jia S, Qu T, Wang X, Feng M, Yang Y, Feng
X, Ma R, Li W, Hu Y, Feng Y, et al: KIAA1199 promotes migration and
invasion by Wnt/beta-catenin pathway and MMPs mediated EMT
progression and serves as a poor prognosis marker in gastric
cancer. PLoS One. 12:e01750582017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang G, Fu Y, Liu G, Ye Y and Zhang X:
miR-218 inhibits proliferation, migration, and EMT of gastric
cancer cells by targeting WASF3. Oncol Res. 25:355–364. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiang J, Fu X, Ran W and Wang Z: Grhl2
reduces invasion and migration through inhibition of TGFβ-induced
EMT in gastric cancer. Oncogenesis. 6:e2842017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu J, Liu D, Niu H, Zhu G, Xu Y, Ye D, Li
J and Zhang Q: Resveratrol reverses Doxorubicin resistance by
inhibiting epithelial-mesenchymal transition (EMT) through
modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin
Cancer Res. 36:192017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Y, Zhang J, Yan Y, Cai H, Li M, Sun
K, Wang J, Liu X, Wang J and Duan X: Low expression of Rap1GAP is
associated with epithelial-mesenchymal transition (EMT) and poor
prognosis in gastric cancer. Oncotarget. 8:8057–8068.
2017.PubMed/NCBI
|
|
8
|
Carino A, Graziosi L, D'Amore C, Cipriani
S, Marchianò S, Marino E, Zampella A, Rende M, Mosci P, Distrutti
E, et al: The bile acid receptor GPBAR1 (TGR5) is expressed in
human gastric cancers and promotes epithelial-mesenchymal
transition in gastric cancer cell lines. Oncotarget. 7:61021–61035.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu XJ, Lin YJ, Chen W, Wang YH, Qiu LQ,
Cai CX, Xiong Q, Chen F, Chen LH, Zhou Q and Li JH: Physiological
study on association between nicotinamide N-methyltransferase gene
polymorphisms and hyperlipidemia. Biomed Res Int. 2016:75219422016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li JH, Chen W, Zhu XJ, Lin YJ, Qiu LQ, Cai
CX, Wang YH, Xiong Q, Chen F and Chen LH: Associations of
nicotinamide N-methyltransferase gene single nucleotide
polymorphisms with sport performance and relative maximal oxygen
uptake. J Sports Sci. 35:2185–2190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen C, Wang X, Huang X, Yong H, Shen J,
Tang Q, Zhu J, Ni J and Feng Z: Nicotinamide N-methyltransferase: A
potential biomarker for worse prognosis in gastric carcinoma. Am J
Cancer Res. 6:649–663. 2016.PubMed/NCBI
|
|
12
|
Fedorowicz A, Mateuszuk Ł, Kopec G, Skórka
T, Kutryb-Zając B, Zakrzewska A, Walczak M, Jakubowski A, Łomnicka
M, Słomińska E and Chlopicki S: Activation of the nicotinamide
N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in
pulmonary hypertension. Respir Res. 17:1082016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sazci G, Sazci B, Sazci A and Idrisoglu
HA: Association of nicotinamide-N-methyltransferase gene rs694539
variant with epilepsy. Mol Neurobiol. 53:4197–4200. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sartini D, Muzzonigro G, Milanese G,
Pierella F, Rossi V and Emanuelli M: Identification of nicotinamide
N-methyltransferase as a novel tumor marker for renal clear cell
carcinoma. J Urol. 176:2248–2254. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roessler M, Rollinger W, Palme S, Hagmann
ML, Berndt P, Engel AM, Schneidinger B, Pfeffer M, Andres H, Karl
J, et al: Identification of nicotinamide N-methyltransferase as a
novel serum tumor marker for colorectal cancer. Clin Cancer Res.
11:6550–6557. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Haren MJ, Sastre Toraño J, Sartini D,
Emanuelli M, Parsons RB and Martin NI: A rapid and efficient assay
for the characterization of substrates and inhibitors of
nicotinamide N-methyltransferase. Biochemistry. 55:5307–5315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie X, Liu H, Wang Y, Zhou Y, Yu H, Li G,
Ruan Z, Li F, Wang X and Zhang J: Nicotinamide N-methyltransferase
enhances resistance to 5-fluorouracil in colorectal cancer cells
through inhibition of the ASK1-p38 MAPK pathway. Oncotarget.
7:45837–45848. 2016.PubMed/NCBI
|
|
18
|
Lim BH, Cho BI, Kim YN, Kim JW, Park ST
and Lee CW: Overexpression of nicotinamide N-methyltransferase in
gastric cancer tissues and its potential post-translational
modification. Exp Mol Med. 38:455–465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo J, Li M, Meng X, Sui J, Dou L, Tang W,
Huang X, Man Y, Wang S and Li J: MiR-291b-3p induces apoptosis in
liver cell line NCTC1469 by reducing the level of RNA-binding
protein HuR. Cell Physiol Biochem. 33:810–822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Q, He MD, Mao L, Wang X, Jiang YL, Li
M, Lu YH, Yu ZP and Zhou Z: Nicotinamide N-methyltransferase
suppression participates in nickel-induced histone H3 Lysine9
dimethylation in BEAS-2B cells. Cell Physiol Biochem. 41:2016–2026.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neelakantan H, Vance V, Wang HL, McHardy
SF and Watowich SJ: Noncoupled fluorescent assay for direct
real-time monitoring of nicotinamide N-methyltransferase activity.
Biochemistry. 56:824–832. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pissios P: Nicotinamide
N-methyltransferase: More than a vitamin B3 clearance enzyme.
Trends Endocrinol Metab. 28:340–353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong S, Moreno-Navarrete JM, Wei X,
Kikukawa Y, Tzameli I, Prasad D, Lee Y, Asara JM, Fernandez-Real
JM, Maratos-Flier E and Pissios P: Nicotinamide N-methyltransferase
regulates hepatic nutrient metabolism through Sirt1 protein
stabilization. Nat Med. 21:887–894. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou SS, Li D and Zhou Y: Management of
nicotinamide N-methyltransferase overexpression: Inhibit the enzyme
or reduce nicotinamide intake? Diabetologia. 58:2191–2192. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chong Y, Tang D, Gao J, Jiang X, Xu C,
Xiong Q, Huang Y, Wang J, Zhou H, Shi Y and Wang D: Galectin-1
induces invasion and the epithelial-mesenchymal transition in human
gastric cancer cells via non-canonical activation of the hedgehog
signaling pathway. Oncotarget. 7:83611–83626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chong Y, Tang D, Xiong Q, Jiang X, Xu C,
Huang Y, Wang J, Zhou H, Shi Y, Wu X and Wang D: Galectin-1 from
cancer-associated fibroblasts induces epithelial-mesenchymal
transition through β1 integrin-mediated upregulation of Gli1 in
gastric cancer. J Exp Clin Cancer Res. 35:1752016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui Y, Wang Y, Li H, Li Q, Yu Y, Xu X, Xu
B and Liu T: Asparaginyl endopeptidase promotes the invasion and
metastasis of gastric cancer through modulating
epithelial-to-mesenchymal transition and analysis of their
phosphorylation signaling pathways. Oncotarget. 7:34356–34370.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai J, Qian C, Su M, Chen M and Chen J:
Gastrokine-2 suppresses epithelial mesenchymal transition through
PI3K/AKT/GSK3β signaling in gastric cancer. Tumour Biol.
37:12403–12410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding WJ, Zhou M, Chen MM and Qu CY: HOXB8
promotes tumor metastasis and the epithelial-mesenchymal transition
via ZEB2 targets in gastric cancer. J Cancer Res Clin Oncol.
143:385–397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Duan F, Jia D, Zhao J, Wu W, Min L, Song
S, Wu H, Wang L, Wang H, Ruan Y and Gu J: Loss of GFAT1 promotes
epithelial-to-mesenchymal transition and predicts unfavorable
prognosis in gastric cancer. Oncotarget. 7:38427–38439. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan Y, Wang YF, Su HF, Fang N, Zou C, Li
WF and Fei ZH: Decreased expression of the long noncoding RNA
LINC00261 indicate poor prognosis in gastric cancer and suppress
gastric cancer metastasis by affecting the epithelial-mesenchymal
transition. J Hematol Oncol. 9:572016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ruskyte K, Liutkevicienė R, Vilkeviciute
A, Vaitkiene P, Valiulytė I, Glebauskiene B, Kriauciuniene L and
Zaliuniene D: MMP-14 and TGFβ-1 methylation in pituitary adenomas.
Oncol Lett. 12:3013–3017. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang SW, Yang TC, Lin WC, Chang WH, Wang
CC, Lai MK and Lin JY: Nicotinamide N-methyltransferase induces
cellular invasion through activating matrix metalloproteinase-2
expression in clear cell renal cell carcinoma cells.
Carcinogenesis. 32:138–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
